Results 321 to 330 of about 166,368 (358)

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

Allogeneic Haemopoietic Stem Cell Transplantation

2010
The field of allogeneic haemopoietic stem cell transplantation (HSCT) and, increasingly the use of cellular therapy, have continued to evolve since its origins in the early 1900’s. Results are improving constantly mainly due to a combination of better understanding of the underlying biological background and major advances in supportive care.
openaire   +1 more source

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Current treatment and recent progress in gastric cancer

Ca-A Cancer Journal for Clinicians, 2021
Smita S Joshi, Brian D Badgwell
exaly  

Stem cell transplantation allogeneic

The Hematology Journal, 2004
openaire   +2 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

[Allogeneic hematopoietic stem cell transplantation].

La Revue du praticien, 2009
Allogeneic hematopoietic stem cell transplantation is a curative option in different hematologic malignancies. This benefit is traditionally based on the immune anti-tumour effect mediated by the allogeneic immune effectors derived from the graft, usually called "graft versus leukemia".
openaire   +1 more source

Allogeneic haematopoietic stem cell transplantation

2019
This chapter explores the principles and uses of allogeneic haematopoietic stem cell transplantation, including its main uses in poor-risk acute leukaemia and chronic myeloid leukaemia. It discusses the principle of graft-versus-malignancy, and human leucocyte antigen matching and donor sources are described.
openaire   +1 more source

[Allogeneic hematopoietic stem cell transplantations].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2011
Allogeneic hematopoietic stem cell transplantation is the most widely used form of immunotherapy. The allogeneic immune effectors infused with the graft can recognize and eradicate the patients' tumoral cells. The curative potential of allogeneic hematopoietic stem cell transplantation is classically based on two mechanisms: the conditioning myelo ...
openaire   +1 more source

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov, Marion Smits, Priscilla K Brastianos   +2 more
exaly